Mahalo
New York, NY

AURUM INSTITUTE USA

EIN 81-2252111
Health & Wellness Medical Research & Training Patients & families Low-income
Mission

Aurum Institute USA mobilizes U.S. donors and partners to support The Aurum Institute’s evidence-driven research, programs, and health systems strengthening to prevent and treat HIV, tuberculosis and other poverty-related diseases in vulnerable communities.

IRS-recognized 501(c)(3) public charity Contributions are tax-deductible

About AURUM INSTITUTE USA

Aurum Institute USA is the U.S.-based, donor-facing nonprofit arm of The Aurum Institute, connecting U.S. generosity to African-led health research and programs. This profile was verified: EIN 81-2252111 corresponds to the organization’s public tax filings and nonprofit profiles.

The organization supports clinical and implementation research, health programme delivery, and market-access work focused primarily on tuberculosis (TB), HIV and related health system strengthening. Recent organizational reporting (Form 990 filings through 2024) shows operating scale-up with annual revenue around $0.7–1.0M and expanding program activity funding and grant management for Aurum’s global projects.

In the last 2–3 years Aurum USA has highlighted measurable program impacts (for example contributing to expanded access to rifapentine-based TB preventive treatments and community-focused TB programming) and continued partnership with major global health initiatives to translate research into policy and practice.

Notable achievements

Scale-up of rifapentine-based TB preventive treatment

Contributed to global procurement and delivery efforts resulting in over 13 million patient courses of rifapentine-based TB preventive treatment being made available across countries, expanding access to effective TB prevention.

3HP price reduction (2024)

Supported market and access work that helped reduce the price of the 3HP TB preventive regimen (reported in 2024), making short-course TB prevention substantially more affordable and scalable in affected countries.

Policy-informing clinical research

Participated in and supported implementation and clinical research (including studies on TB preventive therapy in pregnancy and community-delivered TB care) whose findings have informed global policy and program design.

At a glance

Total assets
$1.8M
Annual revenue
$1.0M
Tax status
501(c)(3)Public charity
EIN
81-2252111
Location
New York, NY
On Mahalo since
May 2026

Financial figures from the IRS Business Master File, the IRS’s registry of tax-exempt organizations.

Recognition

Registered U.S. 501(c)(3) nonprofit (EIN 81-2252111) with publicly available Form 990 filings.
Operates as the U.S. partner for The Aurum Institute and collaborates with major global health funders and initiatives on TB and HIV programming and research.
Maintains an active web presence and organizational transparency through public filings and nonprofit data platforms, signaling donor-facing operations and accountability.

Is this your organization?

Claim this page to keep it current — add your logo, publish campaigns, and reach the donors and advisors discovering you on Mahalo.

Claim this page